Torsten Arndt

7.1k total citations
38 papers, 1.1k citations indexed

About

Torsten Arndt is a scholar working on Pathology and Forensic Medicine, Clinical Biochemistry and Neurology. According to data from OpenAlex, Torsten Arndt has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 8 papers in Clinical Biochemistry and 7 papers in Neurology. Recurrent topics in Torsten Arndt's work include Alcohol Consumption and Health Effects (20 papers), Metabolism and Genetic Disorders (8 papers) and Folate and B Vitamins Research (7 papers). Torsten Arndt is often cited by papers focused on Alcohol Consumption and Health Effects (20 papers), Metabolism and Genetic Disorders (8 papers) and Folate and B Vitamins Research (7 papers). Torsten Arndt collaborates with scholars based in Germany, Netherlands and Sweden. Torsten Arndt's co-authors include Axel M. Gressner, Jos P.M. Wielders, Rolf Hackler, John B. Whitfield, François Schellenberg, Raymond F. Anton, Anders Helander, Janine Reis, Thomas Keller and Jürgen Kropf and has published in prestigious journals such as Clinical Chemistry, Tetrahedron and Pharmacology & Therapeutics.

In The Last Decade

Torsten Arndt

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Arndt Germany 18 552 343 276 149 117 38 1.1k
Dharam P. Agarwal Germany 21 1.0k 1.8× 619 1.8× 382 1.4× 180 1.2× 89 0.8× 51 1.7k
Joanne E. Cluette‐Brown United States 21 369 0.7× 506 1.5× 197 0.7× 134 0.9× 28 0.2× 52 1.5k
Frank Lundquist Denmark 24 670 1.2× 449 1.3× 311 1.1× 308 2.1× 92 0.8× 44 1.7k
H Orrego Canada 26 1.1k 1.9× 297 0.9× 1.1k 4.2× 292 2.0× 84 0.7× 60 2.2k
Abdulaziz A. Al‐Yahya Saudi Arabia 16 248 0.4× 246 0.7× 48 0.2× 45 0.3× 16 0.1× 24 903
Panagiota Nikolaou Greece 22 120 0.2× 318 0.9× 196 0.7× 205 1.4× 105 0.9× 52 1.2k
János Pálóczi United States 16 147 0.3× 183 0.5× 190 0.7× 83 0.6× 27 0.2× 19 802
Andrea Ferrigno Italy 24 133 0.2× 421 1.2× 515 1.9× 122 0.8× 35 0.3× 90 1.6k
Matao Sakanashi Japan 17 135 0.2× 312 0.9× 72 0.3× 74 0.5× 19 0.2× 118 1.2k
A.B. Makar United States 16 215 0.4× 196 0.6× 27 0.1× 28 0.2× 193 1.6× 22 948

Countries citing papers authored by Torsten Arndt

Since Specialization
Citations

This map shows the geographic impact of Torsten Arndt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Arndt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Arndt more than expected).

Fields of papers citing papers by Torsten Arndt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Arndt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Arndt. The network helps show where Torsten Arndt may publish in the future.

Co-authorship network of co-authors of Torsten Arndt

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Arndt. A scholar is included among the top collaborators of Torsten Arndt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Arndt. Torsten Arndt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gressner, Axel M. & Torsten Arndt. (2019). Red Cell Distribution Width. PubMed. 45(4). 2038–2038.
2.
Helander, Anders, Jos P.M. Wielders, Raymond F. Anton, et al.. (2017). Reprint of Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clinica Chimica Acta. 467. 15–20. 20 indexed citations
3.
Arndt, Torsten, et al.. (2017). Lessons learned from a case of tert -butyl glucuronide excretion in urine — “New” psychoactive alcohols knocking on the back door?. Forensic Science International. 281. 9–12. 1 indexed citations
4.
Arndt, Torsten, et al.. (2016). Excessive urinary excretion of isopropyl glucuronide after isopropanol abuse. Forensic Science International. 266. 250–253. 2 indexed citations
5.
Helander, Anders, Jos P.M. Wielders, Raymond F. Anton, et al.. (2016). Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clinica Chimica Acta. 459. 19–24. 35 indexed citations
6.
Arndt, Torsten, et al.. (2014). Cross-reaction of propyl and butyl alcohol glucuronides with an ethyl glucuronide enzyme immunoassay. Forensic Science International. 241. 84–86. 8 indexed citations
7.
Arndt, Torsten, et al.. (2014). Inhalation but not transdermal resorption of hand sanitizer ethanol causes positive ethyl glucuronide findings in urine. Forensic Science International. 237. 126–130. 31 indexed citations
8.
Lötsch, Jörn, Alexandra Doehring, Jeffrey S. Mogil, et al.. (2013). Functional genomics of pain in analgesic drug development and therapy. Pharmacology & Therapeutics. 139(1). 60–70. 55 indexed citations
9.
Arndt, Torsten, et al.. (2013). Ethyl glucuronide identified in commercial hair tonics. Forensic Science International. 231(1-3). 195–198. 21 indexed citations
10.
Arndt, Torsten, et al.. (2012). False-positive ethyl glucuronide immunoassay screening caused by a propyl alcohol-based hand sanitizer. Forensic Science International. 223(1-3). 359–363. 21 indexed citations
11.
Arndt, Torsten, et al.. (2010). Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer. Forensic Science International. 208(1-3). 47–52. 80 indexed citations
12.
Arndt, Torsten, et al.. (2008). Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clinica Chimica Acta. 394(1-2). 42–46. 42 indexed citations
13.
Arndt, Torsten, et al.. (2008). False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC–MS/MS and self-medication. Forensic Science International. 184(1-3). e27–e29. 26 indexed citations
14.
Arndt, Torsten, et al.. (2007). Forensic analysis of carbohydrate-deficient transferrin (CDT) by HPLC—Statistics and extreme CDT values. Forensic Science International. 175(1). 27–30. 14 indexed citations
15.
Tzvetkov, Nikolay, Torsten Arndt, & Jochen Mattay. (2007). Synthesis of angularly fused cyclopentanoids and analogous tricycles via photoinduced ketyl radical/radical anion fragmentation–cyclization reactions. Tetrahedron. 63(42). 10497–10510. 14 indexed citations
16.
Reis, Janine, et al.. (2006). Modulation of Human Motor Cortex Excitability by Single Doses of Amantadine. Neuropsychopharmacology. 31(12). 2758–2766. 44 indexed citations
17.
Arndt, Torsten, Ursula Meier, Markus Nauck, & Axel M. Gressner. (2006). Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: Experience with four independent CDT analysis methods. Clinica Chimica Acta. 372(1-2). 184–187. 19 indexed citations
18.
Arndt, Torsten, et al.. (2005). Determination of serum amantadine by liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta. 359(1-2). 125–131. 38 indexed citations
19.
20.
Préhu, Claude, Rüdiger Neumann, J. Riou, et al.. (2002). A NEW UNSTABLE HEMOGLOBIN VARIANT WITH LOW OXYGEN AFFINITY: Hb ILMENAU [β41(C7)Phe→Cys]. Hemoglobin. 26(2). 169–174. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dharam P. Agarwal Breakdown of academic impact, for papers by Joanne E. Cluette‐Brown Breakdown of academic impact, for papers by Frank Lundquist Breakdown of academic impact, for papers by H Orrego Breakdown of academic impact, for papers by Abdulaziz A. Al‐Yahya Breakdown of academic impact, for papers by Panagiota Nikolaou Breakdown of academic impact, for papers by János Pálóczi Breakdown of academic impact, for papers by Andrea Ferrigno Breakdown of academic impact, for papers by Matao Sakanashi Breakdown of academic impact, for papers by A.B. Makar
Rankless by CCL
2026